Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 104, Issue 40, Pages 15847-15851Publisher
NATL ACAD SCIENCES
DOI: 10.1073/pnas.0705749104
Keywords
cell cycle; cyclin D; estrogen; glycogen; synthase kinase 3 beta(GSK3 beta); estrogen receptor
Categories
Funding
- NCI NIH HHS [P30 CA013330, R01 CA89617, R01 CA089617, P30 CA13330] Funding Source: Medline
Ask authors/readers for more resources
Estradiol-17 beta(E-2) causes cell proliferation in the uterine epithelium of mice and humans by signaling through its transcription factor receptor a (ER alpha). In this work we show that this signaling is mediated by the insulin-like growth factor 1 receptor (IGF1R) expressed in the epithelium, whose activation leads to the stimulation of the phosphoinositide 3-kinase/protein kinase B pathway leading to cyclin 1311 nuclear accumulation and engagement with the canonical cell cycle machinery. This cyclin D1 nuclear accumulation results from the inhibition of glycogen synthase kinase 3 beta (GSK3 beta) activity caused by an inhibitory phosphorylation by protein kinase B. Once the IGF1 pathway is activated, inhibition of ER signaling demonstrates that it is independent of ER. Inhibition of GSK3 beta in the absence of E2 is sufficient to induce uterine epithelial cell proliferation, and GSK3 beta is epistatic to IGF1 signaling, indicating a linear pathway from E2 to cyclin D1. Exposure to E2 is the major risk factor for endometrial cancer, suggesting that downstream activation of this IGF1-mediated pathway by mutation could be causal in the progression to ER-independent tumors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available